Dar Zavain
SEC CIK 1852075 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RXRX | RECURSION PHARMACEUTICALS, INC. | Dir | 240.8K | — | $181.3K | 23 | 2021-12-07 | 2026-07-01 |
Most active insiders at RXRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Borgeson Blake | Dir | — | $4.10M |
| 2 | Gibson Christopher | Dir | — | $3.84M |
| 3 | Khan Najat | Chief R, D Commercial Off, Dir | — | $806.7K |
| 4 | Taylor Ben R | CFO | — | $157.7K |
| 5 | Bumpus Namandje | Dir | — | $28.1K |
| 6 | Michor Franziska | Dir | — | — |
| 7 | Hallett David | CSO | — | — |
| 8 | Dar Zavain | Dir | — | — |
| 9 | Li Dean Y | Dir | — | — |
| 10 | Sun Elaine D | Dir | — | — |
Transactions 23
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-02 17:15 | 2026-07-01 | RXRX | RECURSION PHARMACEUTICALS, INC. | Dar Zavain | Dir | A - Grant | $0.00 | +5,109 | 240.8K | +2% | $0 | |
| 2026-06-22 16:32 | 2026-06-17 | RXRX | RECURSION PHARMACEUTICALS, INC. | Dar Zavain | Dir | A - Grant | $0.00 | +88.4K | 235.7K | +60% | $0 | |
| 2026-04-02 16:56 | 2026-04-01 | RXRX | RECURSION PHARMACEUTICALS, INC. | Dar Zavain | Dir | A - Grant | $0.00 | +4,902 | 147.2K | +3% | $0 | |
| 2026-01-06 | 2026-01-02 | RXRX | RECURSION PHARMACEUTICALS, INC. | Dar Zavain | Dir | A - Grant | $0.00 | +3,571 | 142.3K | +3% | $0 | |
| 2025-10-03 | 2025-10-01 | RXRX | RECURSION PHARMACEUTICALS, INC. | Dar Zavain | Dir | A - Grant | $0.00 | +2,941 | 138.8K | +2% | $0 | |
| 2025-07-03 | 2025-07-01 | RXRX | RECURSION PHARMACEUTICALS, INC. | Dar Zavain | Dir | A - Grant | $0.00 | +2,924 | 135.8K | +2% | $0 | |
| D | 2025-06-23 | 2025-06-18 | RXRX | RECURSION PHARMACEUTICALS, INC. | Dar Zavain | Dir | A - Grant | $0.00 | +22.0K | 132.9K | +20% | $0 |
| 2025-04-03 | 2025-04-01 | RXRX | RECURSION PHARMACEUTICALS, INC. | Dar Zavain | Dir | A - Grant | $0.00 | +2,745 | 110.9K | +3% | $0 | |
| 2025-01-06 | 2025-01-02 | RXRX | RECURSION PHARMACEUTICALS, INC. | Dar Zavain | Dir | A - Grant | $0.00 | +1,907 | 108.1K | +2% | $0 | |
| 2024-10-04 | 2024-10-01 | RXRX | RECURSION PHARMACEUTICALS, INC. | Dar Zavain | Dir | A - Grant | $0.00 | +2,229 | 106.2K | +2% | $0 | |
| 2024-07-03 | 2024-07-01 | RXRX | RECURSION PHARMACEUTICALS, INC. | Dar Zavain | Dir | A - Grant | $0.00 | +1,843 | 104.0K | +2% | $0 | |
| D | 2024-06-05 | 2024-06-03 | RXRX | RECURSION PHARMACEUTICALS, INC. | Dar Zavain | Dir | A - Grant | $0.00 | +13.1K | 102.2K | +15% | $0 |
| 2024-04-03 | 2024-04-01 | RXRX | RECURSION PHARMACEUTICALS, INC. | Dar Zavain | Dir | A - Grant | $0.00 | +1,467 | 89.1K | +2% | $0 | |
| 2024-01-04 | 2024-01-02 | RXRX | RECURSION PHARMACEUTICALS, INC. | Dar Zavain | Dir | A - Grant | $0.00 | +1,393 | 55.2K | +3% | $0 | |
| 2023-12-18 | 2023-12-14 | RXRX | RECURSION PHARMACEUTICALS, INC. | Dar Zavain | Dir | S - Sale | $9.00 | -20.1K | 53.8K | -27% | -$181.3K | |
| 2023-10-04 | 2023-10-02 | RXRX | RECURSION PHARMACEUTICALS, INC. | Dar Zavain | Dir | A - Grant | $0.00 | +1,920 | 74.0K | +3% | $0 | |
| 2023-07-06 | 2023-07-03 | RXRX | RECURSION PHARMACEUTICALS, INC. | Dar Zavain | Dir | A - Grant | $0.00 | +1,863 | 72.0K | +3% | $0 | |
| D | 2023-06-21 | 2023-06-16 | RXRX | RECURSION PHARMACEUTICALS, INC. | Dar Zavain | Dir | A - Grant | $0.00 | +12.6K | 70.2K | +22% | $0 |
| A | 2023-04-28 | 2023-04-03 | RXRX | RECURSION PHARMACEUTICALS, INC. | Dar Zavain | Dir | A - Grant | $0.00 | +1,996 | 57.6K | +4% | $0 |
| 2023-04-05 | 2023-04-03 | RXRX | RECURSION PHARMACEUTICALS, INC. | Dar Zavain | Dir | A - Grant | $0.00 | +1,996 | 22.6K | +10% | $0 | |
| 2022-07-12 | 2022-07-08 | RXRX | RECURSION PHARMACEUTICALS, INC. | Dar Zavain | Dir | J - Other | $0.00 | +2,420 | 20.6K | +13% | $0 | |
| D | 2022-06-16 | 2022-06-14 | RXRX | RECURSION PHARMACEUTICALS, INC. | Dar Zavain | Dir | A - Grant | $0.00 | +18.1K | 18.1K | New | $0 |
| 2021-12-09 | 2021-12-07 | RXRX | RECURSION PHARMACEUTICALS, INC. | Dar Zavain | Dir | J - Other | $0.00 | +3,599 | 3,599 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations